Effects of Messaging App Reminder on the Compliance of Zero-Time Exercise (ZTEx)

September 23, 2023 updated by: YEUNG Wing Fai, The Hong Kong Polytechnic University

Effects of Messaging App Reminder on the Compliance of Zero-Time Exercise (ZTEx): A Nested Proof-of-concept Pilot Study

This is a proof-of-concept pilot nested in the RCT titled, 'Zero-time Exercise on Inactive Adults With Insomnia Disorder'. It aims to evaluate the effects of a simple WhatsApp intervention on exercise adherence and on sleep and related outcomes.

Study Overview

Detailed Description

This is the second phase of another study - 'Zero-time Exercise on Inactive Adults With Insomnia Disorder'.

In the first phase (baseline to week 8), 136 subjects will be randomly allocated to the ZTEx intervention or the sleep hygiene education (SHE) comparison group. They will receive two 2-hour ZTEx training or SHE lessons and practice ZTEx or follow the sleep hygiene instruction for 24 weeks.

The second phase of the study (weeks 9-24)will commence after completion of the assessment of the RCT at week 8. Subjects in the Zero-time Exercise (ZTEx) group will be randomly divided into either an ZTEx with WhatsApp reminder (ZTEx+R) group or an ZTEx without WhatsApp reminder (ZTEx alone) group to evaluate the effects of WhatsApp reminders on exercise adherence and sleep and related outcomes.

Study Type

Interventional

Enrollment (Actual)

68

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Hong Kong, Hong Kong
        • School of Nursing, the Hong Kong Polytechnic University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. Hong Kong residents,
  2. ethnic Chinese aged 18-65 years with the ability to communicate in Cantonese or Putonghua,
  3. who fulfil the DSM-5 diagnostic criteria for insomnia disorder according to a validated diagnostic tool, the Brief Insomnia Questionnaire (we include primary insomnia because it is more homogenous and less complicated than comorbid insomnia; if ZTEx is found to be effective for primary insomnia, then comorbid insomnia can be targeted in future studies),
  4. scored at least 10 points in the Insomnia Severity Index,
  5. are ambulant and can independently perform daily activities,
  6. are physically inactive, defined as not having participated in at least 150 min of moderate intensity or 75 min of vigorous intensity physical activity a week, or the equivalent combination over the previous 3 months by self-report
  7. have a smartphone compatible with WhatsApp, and
  8. willing to give informed consent

Exclusion Criteria:

  1. any current diagnosis fulfilling the DSM-IV criteria of a major depressive disorder, generalized anxiety disorders, post-traumatic stress disorder, panic disorder, substance use disorders, or schizophrenia as screened using the Chinese version of the Structured Clinical Interview for DSM-IV;
  2. other sleep disorders, including circadian rhythm disorder, narcolepsy, obstructive sleep apnoea (OSA), and restless leg syndrome (RLS)/periodic leg movement disorder (PLMD) as determined based on cut-off scores (≥ 7 on narcolepsy; ≥ 8 on circadian rhythm disorder; ≥ 15 on OSA; ≥ 7 on RLS/PLMD) using SLEEP-50. If in doubt, subjects will be referred to our team psychiatrist (KF Chung) for further assessment;
  3. any current medical conditions or side-effects of medication that are contributing significantly to the subject's insomnia;
  4. taking medications or currently participating in other psychotherapies for insomnia or other psychiatric disorders;
  5. impaired cognitive functioning (<22 points in HK-MoCA) or with difficulty in giving consent or understanding instructions;
  6. pregnant;
  7. shift work;
  8. whose physical condition is such that physicians recommend that they refrain from exercising; and
  9. fulfilling the criterion for obesity for Asians (body mass index, of 27.5 or above)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Zero Time Exercise training + WhatsApp anti-inertia reminders
Subjects in this group will receive daily WhatsApp anti-inertia reminders from the research assistant to remind and encourage them to practice Zero Time Exercise.

Zero Time Exercise encourage people to increase physical exercise by simple movements that can be done any time at any places. We offer a 2-session training course to train the subjects to do zero-time exercise.

In addition, WhatsApp anti-inertia reminders will be sent daily by the research assistant to remind and encourage the participants to practice the Zero Time Exercise.

Active Comparator: Zero Time Exercise training alone
Subjects in this group will not receive any WhatsApp reminders from week 8 to 24.
Zero Time Exercise encourage people to increase physical exercise by simple movements that can be done any time at any places. We offer a 2-session training course to train the subjects to do zero-time exercise.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Insomnia Severity Index
Time Frame: week 8, week 16, week 24
The subjects rate the severity of insomnia, the distress, and the functional impairment associated with insomnia on a 5-point scale. The score ranges from 0 to 28. The higher the score, the worse the outcome is.
week 8, week 16, week 24
Change in the intervention adherence
Time Frame: week 8, week 16, week 24
Patients will be told to record their daily physical activities or sleep health hygiene compliance onto the log.
week 8, week 16, week 24

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sleep diary (7-day)
Time Frame: week 8, week 16, week 24
The standardized sleep diary records the daily bedtime and rising time, from which the total time in bed (TIB) can be calculated.
week 8, week 16, week 24
Hospital Anxiety and Depression Scale
Time Frame: week 8, week 16, week 24
The Hospital Anxiety and Depression Scale is a 14-items self-administered questionnaire, which assesses the severity of depressive and anxiety symptoms. The score ranges from 0-21 for either depression or anxiety. The higher the score, the worse the outcome is.
week 8, week 16, week 24
Multidimensional fatigue inventory-20
Time Frame: week 8, week 16, week 24
Multidimensional fatigue inventory-20 is a 20-items self-report instrument designed to measure severity of fatigue. The score ranges from 20 to 100. The higher the score, the worse the outcome is.
week 8, week 16, week 24
Actigraphy (7-day)
Time Frame: week 8, week 16, week 24
Actigraphy measures wrist movements to assess sleep or waking state, is accomplished through an accelerometer in a wrist worn device.
week 8, week 16, week 24
Accelerometer (7-day)
Time Frame: week 8, week 16, week 24
Accelerometer measures wrist movements to assess the physical activity levels.
week 8, week 16, week 24
Change in WAIS-IV Digit Span forward test
Time Frame: week 8, week 16, week 24
Change in Wechsler Adult Intelligence Scale, 4th edition (WAIS-IV) Digit Span forward test score will be used to measure the attention function.
week 8, week 16, week 24
Change in WAIS-IV Color Trails Test
Time Frame: week 8, week 16, week 24
Change in Wechsler Adult Intelligence Scale, 4th edition (WAIS-IV) Color Trails Test score will be used to measure the attention function.
week 8, week 16, week 24
Change in WAIS-IV Stroop color-word Test
Time Frame: week 8, week 16, week 24
Change in Wechsler Adult Intelligence Scale, 4th edition (WAIS-IV) Stroop color-word Test score will be used to measure the attention function.
week 8, week 16, week 24
Change in the Hong Kong List Learning Test (HKLLT)
Time Frame: week 8, week 16, week 24
Change in HKLLT Test score will be used to measure the memory function.
week 8, week 16, week 24
Change in Digit Span-backward and forward test
Time Frame: week 8, week 16, week 24
Change in Digit Span-backward and forward test score will be used to measure the memory function.
week 8, week 16, week 24
Change in the interference index of Color Trails Test
Time Frame: week 8, week 16, week 24
Change in the interference index of Color Trails Test score will be used to measure the executive function
week 8, week 16, week 24
Change in the interference index of Stroop color-word Test
Time Frame: week 8, week 16, week 24
Change in the interference index of Stroop color-word Test score will be used to measure the executive function
week 8, week 16, week 24
Change in the Wisconsin Card Sorting Test
Time Frame: week 8, week 16, week 24
Change in the Wisconsin Card Sorting Test score will be used to measure the executive function
week 8, week 16, week 24

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: WF Yeung, School of Nursing, the Hong Kong Polytechnic University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 31, 2020

Primary Completion (Actual)

June 30, 2023

Study Completion (Actual)

June 30, 2023

Study Registration Dates

First Submitted

January 6, 2020

First Submitted That Met QC Criteria

January 10, 2020

First Posted (Actual)

January 13, 2020

Study Record Updates

Last Update Posted (Actual)

September 26, 2023

Last Update Submitted That Met QC Criteria

September 23, 2023

Last Verified

September 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Insomnia, Primary

3
Subscribe